LaurenElizabethDockeryMD

PubMed

• Developing a novel image marker to predict the clinical outcome of neoadjuvant chemotherapy (NACT) for ovarian cancer patients.
  Ke Zhang, Neman Abdoli, Patrik Gilley, Youkabed Sadri, Xuxin Chen, Theresa C Thai, Lauren Dockery, Kathleen Moore, Robert S Mannel, Yuchen Qiu> ;Computers in Biology and Medicine. 2024 Apr 1
• Evaluating the Effectiveness of 2D and 3D CT Image Features for Predicting Tumor Response to Chemotherapy.
  Neman Abdoli, Ke Zhang, Patrik Gilley, Xuxin Chen, Youkabed Sadri, Theresa Thai, Lauren Dockery, Kathleen Moore, Robert Mannel, Yuchen Qiu> ;Bioengineering. 2023 Nov 20
• 2 citations
  The role and participation of immune cells in the endometrial tumor microenvironment.
  Debasish Kumar Dey, Danielle Krause, Rajani Rai, Swati Choudhary, Lauren E Dockery, Vishal Chandra> ;Pharmacology & Therapeutics. 2023 Nov 1
• 3 citations
  A phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometrium.
  C G Jackson, K N Moore, L Cantrell, B K Erickson, L R Duska, D L Richardson, L M Landrum, L L Holman, J L Walker, R S Mannel, K M Moxley, L Queimado, A Cohoon, K Ding,...> ;Gynecologic Oncology. 2022 Jul 1
• Niraparib in the treatment of previously treated advanced ovarian, fallopian tube or primary peritoneal cancer.
  Bobbie J. Rimel, Lauren Dockery, Leslie M Randall, Kathleen N. Moore> ;Future Oncology. 2020 Sep 3
• 5 citations
  Extending the platinum-free interval: The impact of omitting 2nd line platinum chemotherapy in intermediate platinum-sensitive ovarian cancer
  L.E. Dockery, Abby R. Rubenstein, Kai Ding, Sarah G. Mashburn, Wesley C. Burkett, A.M. Davis, David W. Doo, Rebecca C. Arend, Kathleen N. Moore, Camille C. Gunderson> ;Gynecologic Oncology. 2019 Nov 1
• 8 citations
  Improving cancer care for American Indians with cervical cancer in the Indian Health Service (IHS) system - Navigation may not be enough.
  L.E. Dockery, Anita Motwani, Kai Ding, Mark P. Doescher, Justin D. Dvorak, Kathleen N. Moore, Laura L. Holman> ;Gynecologic Oncology. 2018 Apr 1
• 28 citations
  Tolerance and toxicity of the PARP inhibitor olaparib in older women with epithelial ovarian cancer.
  L.E. Dockery, William P. Tew, Kai Ding, Kathleen N. Moore> ;Gynecologic Oncology. 2017 Dec 1
• Join now to see all